Understanding the Value of Mergers and Acquisitions in Life Sciences

Mergers and acquisitions (M&A) play a critical role in the healthcare industry. As more products come to market, companies can leverage M&A to elevate their position in the market. The value of mergers and acquisitions in the pharmaceutical industry is understood and echoed across life sciences acquisitions. LifeSciencesIntelligence spoke to three industry leaders to understand the existing M&A landscape and what to expect moving forward: Daniel Chancellor, Director of Thought Leadership for Evaluate (a Norstella company); Gadi Saarony, CEO of Advarra; and Joel Morse, CEO and Co-Founder of Curavit Clinical Research.

Read the full article: Understanding the Value of Mergers and Acquisitions in Life Sciences //

Source: https://lifesciencesintelligence.com/features/understanding-the-value-of-mergers-and-acquisitions-in-life-sciences

Leave a Comment

Your email address will not be published.

Scroll to Top